SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-096627
Filing Date
2024-08-14
Accepted
2024-08-14 06:10:47
Documents
13
Period of Report
2024-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elym-20240814.htm   iXBRL 8-K 53642
2 EX-99.1 elym-ex99_1.htm EX-99.1 101615
3 GRAPHIC img171973770_0.jpg GRAPHIC 60643
  Complete submission text file 0000950170-24-096627.txt   368297

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT elym-20240814.xsd EX-101.SCH 29830
15 EXTRACTED XBRL INSTANCE DOCUMENT elym-20240814_htm.xml XML 4724
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 241203947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)